A World Health Organization (WHO) report has found no adverse health outcomes but rather several medical applications for cannabidiol, a.k.a. CBD, despite U.S. federal policy on this cannabinoid chemical.
Cannabis News
Canadian cannabis companies get $2 Billion Investment, 2 times more than the entire global legalized cannabis industry
Canadian cannabis companies are on a fundraising spree. New York-based Viridian Capital Advisors has reported, that Canadian cannabis industry has got $2b as investment following the announcement of legalization processes.
Liberals reach deal with the provinces on sharing pot tax revenue, with price pegged at about $10 a gram
Agreement gives provinces 75% of tax revenues from legal cannabis sales, caps federal share at $100M
Aphria Inc. Announces $100 Million Bought Deal
Aphria Inc. (TSX:APH) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters pursuant to which the Underwriters have agreed to purchase, on a "bought deal" basis, 7,272,740 Common Shares of the Company at a price of C$13.75 per Common Share for aggregate gross proceeds to the Company of C$100,000,175.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Granted U.S. Patent Regarding DehydraTECH™ Technology
Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) reported this morning that it has been granted a patent from the United States Patent and Trademark Office (“USPTO”) increasing its intellectual property (“IP”) hold of its DehydraTECH™ technology.
Maricann Group Inc. Announces $20 Million Private Placement
Expansion Will Allow up to 95,000 kg of Dry Flower Production Capacity.
Aurora Cannabis and CannaRoyalty Sign Letter of Intent for International Drug Delivery Technology Agreement
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) today announced that the companies have signed a binding Letter of Intent, giving Aurora the exclusive right for 90 days to negotiate a final licensing agreement.
SinglePoint, Inc. (SING) Reports Key 2017 JV Achievements; Eyes Next Year’s Initiatives
SinglePoint (OTC: SING) today announced considerable growth in 2017 and success in key advances of its corporate mission with the launch of additional joint ventures and the closing of new deals within existing agreements.
Medical Cannabis Payment Solutions (REFG) Empowers Clients, Consumers with Cannabis Payment Solutions
Medical Cannabis Payment Solutions (OTC: REFG), based in Cheyenne, Wyoming, is a pioneer in the cannabis payment solutions arena with its proprietary merchant processing system.
Dangerous Opioid Side Effects Shifts Market Focus to Cannabis for Chronic Pain
The need for alternatives like cannabinoid-based therapies is generating significant market interest for prospective solution developers such as InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF)
ABcann Enters into Agreement to Acquire Leading Medical Cannabis Clinic
ABcann Global Corporation (TSXV:ABCN OTC: ABCCF) is pleased to announce that it has entered into a binding letter of intent dated December 11, 2017 to acquire all of the outstanding securities of Harvest Medicine Inc..
GW Pharma Closes $317.4 Million Equity Offering
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exercise of Underwriter’s Option to Purchase Additional ADSs
Aurora Cannabis Boosts Radient Technologies Stake to 17.2%
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies Inc. (TSX-V: RTI) today announced that Aurora has completed its previously announced $12 million strategic investment in Radient.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Inks LOI to Acquire Outstanding Shares of Harvest Medicine Inc.
Abcann Global (TSX.V: ABCN) (OTCQB: ABCCF) this morning said that the company recently entered into a binding Letter of Intent (“LOI”) dated December 11, 2017 to acquire all outstanding securities of Canada’s fastest growing medical cannabis clinic, Harvest Medicine Inc.
The Therapeutic Potential of Pharmacologically Active Cannabinoids
InMed Pharmaceuticals, Inc. (CSE: IN) (OTC: IMLFF) has initiated a scientific paradigm shift in discovering potential breakthrough cannabinoid-based therapies that advances far beyond basic cannabinoid production and the over-the-counter sales of oils and elixirs.